India to have covid vaccine by June: Kiran Mazumdar-Shaw
Biocon on Friday reported a 23.01% fall in its consolidated net profit to ₹195.4 crore for the second quarter ended September 30, mainly on account of higher expenses.
The buzz around an imminent covid-19 vaccine has raised hopes of a way back to normalcy for the billions affected by the pandemic around the world, said Kiran Mazumdar-Shaw, chairperson and managing director of Bengaluru-based Biocon Ltd. Mazumdar-Shaw is hopeful that the vaccine will be in India by June, but added delivering the vaccine to India’s over 1.2 billion population has its own challenges.
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more